Trials / Conditions / Epithelial Tumor
Epithelial Tumor
7 registered clinical trials studyying Epithelial Tumor — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced NCT07038343 | Avenzo Therapeutics, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Using Tumor Models to Determine Treatments NCT06813079 | University Health Network, Toronto | Phase 2 |
| Completed | Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) NCT05165433 | Akamis Bio | Phase 1 |
| Completed | Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours NCT05043714 | Akamis Bio | Phase 1 |
| Completed | First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector NCT04053283 | Akamis Bio | Phase 1 |
| Completed | First in Human Study of NG-350A (an Oncolytic Adenoviral Vector Which Expresses an Anti-CD40 Antibody) NCT03852511 | Akamis Bio | Phase 1 |
| Completed | Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors NCT02636036 | Akamis Bio | Phase 1 |